16:03 EST Intensity Therapeutics (INTS) files to sell 1.24M shares of common stock for holders
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INTS:
- Intensity Therapeutics reports positive results of INT230-6 in breast cancer
- Intensity Therapeutics presents INT230-6 Phase 1/2 daya in Sarcoma
- Intensity Therapeutics reports Q3 EPS (25c), consensus (30c)
- Is INTS a Buy, Before Earnings?
- Intensity Therapeutics announces first dosing in Phase 2 trial of INT230-6